The Phosphoproteome of the Rd1 Mouse Retina, a Model of Inherited Photoreceptor Degeneration, Changes after Protein Kinase G Inhibition
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24129836 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jiaming Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden. Hauptthemen laut MEDLINE: Retinal Degeneration, Retinitis Pigmentosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement, The Stiftelsen Hedda och John Forssmans, Stiftelsen för Synskadade i f.d. Malmöhus län.
Abstract (Originalsprache)
Retinitis pigmentosa (RP) is a frequent cause of blindness among the working population in industrial countries due to the inheritable death of photoreceptors. Though gene therapy was recently approved for mutations in the RPE65 gene, there is in general no effective treatment presently. Previously, abnormally high levels of cGMP and overactivation of its dependent protein kinase (PKG) have been suggested as causative for the fatal effects on photoreceptors, making it meaningful to explore the cGMP-PKG downstream signaling for more pathological insights and novel therapeutic target development purposes. Here, we manipulated the cGMP-PKG system in degenerating retinas from the rd1 mouse model pharmacologically via adding a PKG inhibitory cGMP-analogue to organotypic retinal explant cultures. A combination of phosphorylated peptide enrichment and mass spectrometry was then applied to study the cGMP-PKG-dependent phosphoproteome. We identified a host of novel potential cGMP-PKG downstream substrates and related kinases using this approach and selected the RAF1 protein, which may act as both a substrate and a kinase, for further validation. This showed that the RAS/RAF1/MAPK/ERK pathway may be involved in retinal degeneration in a yet unclarified mechanism, thus deserving further investigation in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden.
- Mass Spectrometry, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden.
ORCID-Profile: Jiaming Zhou, Charlotte Welinder
Förderung
- European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement
- The Stiftelsen Hedda och John Forssmans
- Stiftelsen för Synskadade i f.d. Malmöhus län
- Kronprinsessan Margaretas Arbetsnämnd för synskadade
- Carmen och Bertil Regnérs Stiftelse för forskning inom området ögonsjukdomar
- Ögonfonden
- European Union’s Horizon 2020 research and innovation programme
- The Royal Physiographic Society of Lund—The Stiftelsen Hedda och John Forssmans fond
Zitieren
APA
Zhou, J., Welinder, C., & Ekström, P. (2023). The Phosphoproteome of the Rd1 Mouse Retina, a Model of Inherited Photoreceptor Degeneration, Changes after Protein Kinase G Inhibition. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129836
Vancouver
Zhou J, Welinder C, Ekström P. The Phosphoproteome of the Rd1 Mouse Retina, a Model of Inherited Photoreceptor Degeneration, Changes after Protein Kinase G Inhibition. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129836
BibTeX
@article{Zhou2023,
author = {Zhou, Jiaming and Welinder, Charlotte and Ekström, Per},
title = {The Phosphoproteome of the Rd1 Mouse Retina, a Model of Inherited Photoreceptor Degeneration, Changes after Protein Kinase G Inhibition},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24129836}
}
EUVIMED